We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Contrast Extravasation: A Surrogate Marker of Primary Intracerebral Hemorrhage and Secondary Expansion—Reply

Shyam Prabhakaran, MD, MS
Arch Neurol. 2012;69(2):278. doi:10.1001/archneurol.2011.2130.
Text Size: A A A
Published online


In reply

We thank Drs Huynh and Aviv for their correspondence. There is great interest in the topic of hematoma expansion because it represents one of few therapeutic targets with the potential to reduce mortality and disability in patients with intracerebral hemorrhage (ICH). Our case report confirms that the onset of ICH is characterized by an active breach of the blood-brain barrier and the rapid expulsion of blood products into the parenchyma that continues until hematoma stabilization. It is believed that, in spontaneous ICH, hematoma growth occurs primarily in the first 6 hours. Thus, this narrow window may represent the only opportunity to intervene early enough to reduce the final size of the hematoma and, with it, the considerable morbidity and mortality associated with ICH. Contrast extravasation in the early hours after ICH onset, the “Spot Sign” in computed tomographic studies, may be a reliable marker of hematoma expansion and could be used to select patients with ICH who may benefit from hemostatic treatments such as recombinant factor VIIa.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





February 1, 2012
Thien J. Huynh, MD; Richard I. Aviv, MBChB
Arch Neurol. 2012;69(2):278. doi:10.1001/archneurol.2011.1213.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Supplemental Content

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Stroke, Hemorrhagic: Does This Patient Have a Hemorrhagic Stroke?